Document Details
Form
Filing Date
Jun 4, 2021
Document Date
Jun 4, 2021
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Aligos Therapeutics
Issuer
Aligos Therapeutics, Inc.
